Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 9 |
---|
Ligand | BDBM50206421 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_462167 (CHEMBL944995) |
---|
IC50 | 1280±n/a nM |
---|
Citation | Peifer, C; Urich, R; Schattel, V; Abadleh, M; Röttig, M; Kohlbacher, O; Laufer, S Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors. Bioorg Med Chem Lett18:1431-5 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 9 |
---|
Name: | Mitogen-activated protein kinase 9 |
Synonyms: | JNK-55 | JNK2 | JNK2/JNK3 | MAPK9 | MK09_HUMAN | Mitogen-Activated Protein Kinase 9 (JNK2) | Mitogen-activated protein kinase 8/9 | PRKM9 | SAPK1A | Stress-activated protein kinase JNK2 | c-Jun N-terminal kinase 2 | c-Jun N-terminal kinase 2 (JNK2) |
Type: | Enzyme |
Mol. Mass.: | 48131.49 |
Organism: | Homo sapiens (Human) |
Description: | JNK-2 was purchased from Upstate Cell Signaling Solutions (formerly Upstate Biotechnology). |
Residue: | 424 |
Sequence: | MSDSKCDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP
FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH
MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF
MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ
LGTPSAEFMKKLQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSK
MLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEV
MDWEERSKNGVVKDQPSDAAVSSNATPSQSSSINDISSMSTEQTLASDTDSSLDASTGPL
EGCR
|
|
|
BDBM50206421 |
---|
n/a |
---|
Name | BDBM50206421 |
Synonyms: | 3-(4-fluorophenyl)-5-isopropyl-4-(pyridin-4-yl)isoxazole | 4-(3-(4-fluorophenyl)-5-isopropylisoxazol-4-yl)pyridine | 4-[3-(4-fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine | CHEMBL220227 |
Type | Small organic molecule |
Emp. Form. | C17H15FN2O |
Mol. Mass. | 282.3122 |
SMILES | CC(C)c1onc(c1-c1ccncc1)-c1ccc(F)cc1 |
Structure |
|